FDA issues proposed rule for healthcare cleaning products

The Food and Drug Administration (FDA) has issued a new rule requiring manufacturers of over-the-counter antiseptic products used in healthcare settings to provide further documentation of their safety and effectiveness. Under the rule, manufacturers must submit new studies covering issues such as possible hormonal side effects. Any product that could not prove its safety and effectiveness in the next three years would be subject to removal from the market. "We're not asking for any of these products to come off the market at this time, we're just asking for additional data," Theresa Michele, a director in the FDA's drug center, told the Associated Press. Proposed rule (.pdf)

Suggested Articles

Insurance giant Anthem has reached a settlement with a group of State Attorney Generals over the historic 2015 hack into its computer network.

The Trump administration plans to work with the American Board of Family Medicine to study how health IT tools can be improved for doctors.

The Trump administration is planning to delay the compliance deadlines for information blocking regulations for a second time due to the pandemic.